Hopefully, this will drive policy changes, lower prices, and expand access, while also marking an important shift: seeing obesity as a disease that deserves proactive, evidence-based treatment. While semaglutide is the most prominent of them all, dulaglutide and liraglutide, as well as the dual GLP-1/GIP agonist GIP plays a similar role to GLP-1 tirzepatide, present in Lillys Mounjaro and Zepbound, also join the list as therapeutic alternatives. Even biosimilars, which are drugs that are highly similar to biologics with regard to their quality, safety, and efficacy, were listed
Keep in mind though that the menu is fixed (aside from when the company introduces a new product)
Who can be prescribed Zepbound
If BPC-157's tissue-protective properties translate to humans, the compounds could theoretically be deeply synergistic: one driving fat loss, the other protecting the musculoskeletal architecture during the process
For product evaluation, the practical questions are copper-complex identity, chromatographic purity, lot traceability, and agreement among the COA, HPLC, MS, and compound reference
